~ PEDMARK® Net Product Revenue of $6.5 Million, a 96% Increase Compared to Second Quarter ~ ~ Strong Commercial Uptake Underscoring Significant Unmet Medical Need ~ ~ Received Approval in October.
Fennec Pharmaceuticals Inc. (NASDAQ:FENC) Q2 2023 Earnings Call Transcript August 6, 2023 Operator: Good morning, ladies and gentlemen and welcome to the Fennec Pharmaceuticals Second Quarter 2023 Earnings and Corporate Update Conference Call. [Operator Instructions] As a reminder, today’s conference call is being recorded. Now, I would like to turn the conference over to Fennec’s […]
Fennec Pharmaceuticals Announces Second Quarter 2023 Financial Results and Provides Business Update itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
RESEARCH TRIANGLE PARK, N.C., June 12, 2023 Fennec Pharmaceuticals Inc. today announced that the nominees listed in the management proxy circular dated April 24, 2023 for the Annual General. | June 12, 2023